abstract |
The present invention relates to dinucleoside polyphosphate analogs for use in the inhibition (or down-regulation) of pain through the transmissible ATP-opened P2X3 receptor, often by a high affinity desensitization (HAD) mechanism Or a pharmaceutically acceptable salt thereof. |